Aminowise-BCAA Sachets

L-Valine 1144 mg + L-Isoleucine 952 mg + L-Leucine 1904 mg Sachets — Branched-Chain Amino Acids (Same as Lamino BCAA)

Aminowise-BCAA Sachets — L-Valine 1144 mg + L-Isoleucine 952 mg + L-Leucine 1904 mg per sachet from Trumac Healthcare PCD Pharma Franchise India

Composition L-Valine 1144 mg + L-Isoleucine 952 mg + L-Leucine 1904 mg per sachet
Dosage Form Oral Sachet (Powder)
Pack Type Sachet (Box)
Pack Size 5 x 10 g Sachets
MRP ₹ 745
Therapy Gynaecology + G.P. / Nutraceutical — Branched-Chain Amino Acid (BCAA) Supplement
Storage Store below 30 °C in a dry place, away from direct sunlight.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Aminowise-BCAA Sachets

Aminowise-BCAA Sachets supply the three branched-chain amino acids (L-Valine 1144 mg, L-Isoleucine 952 mg, L-Leucine 1904 mg) in a single-dose oral sachet — directly equivalent in composition to Lamino BCAA Sachets. BCAAs together account for about a third of muscle protein and are the only amino acids metabolised primarily in muscle rather than the liver, making them especially relevant in protein-catabolic and liver-disease states.

Clinically, BCAA supplementation reduces protein loss, supports muscle protein synthesis, and improves nutritional status in patients with chronic liver disease, cirrhosis with hepatic encephalopathy, prolonged convalescence and protein-energy malnutrition. Leucine in particular is a potent activator of the mTOR pathway that triggers muscle anabolism.

Aminowise-BCAA is manufactured by Trumac Healthcare in WHO-GMP and FSSAI compliant nutraceutical facilities. Available for monopoly-based PCD pharma franchise and third-party manufacturing — a specialty hepato-nutraceutical SKU.

Indications

  • Adjunctive nutrition in chronic liver disease and cirrhosis
  • Prevention and management of hepatic encephalopathy
  • Protein-energy malnutrition and sarcopenia
  • Convalescence after surgery or prolonged illness
  • Athletic and high-protein-requirement states (off-label)

Mechanism of Action

BCAAs are oxidised in skeletal muscle rather than the liver, providing energy substrate and lowering muscle protein breakdown. Leucine activates mTORC1, stimulating ribosomal protein synthesis. In hepatic encephalopathy, BCAAs lower the aromatic amino acid : BCAA ratio, reducing false-neurotransmitter formation and improving cognitive function.

Dosage & Administration

Adults: 1 sachet dissolved in 100–150 ml of water or milk, taken twice daily before or between meals; or as directed by a physician.

Side Effects

Generally well tolerated. Possible mild GI upset, nausea, bloating. Rare: hypersensitivity reactions.

Contraindications & Precautions

Hypersensitivity to any component. Inborn errors of BCAA metabolism (maple syrup urine disease). Severe renal impairment requires medical supervision. Caution in patients on amino-acid-restricted diets.

Storage

Store below 30 °C in a dry place, away from direct sunlight.

PCD Pharma Franchise & Third-Party Manufacturing
Aminowise-BCAA Sachets is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Aminowise-BCAA Sachets used for?

Aminowise-BCAA Sachets supply Valine, Isoleucine and Leucine (BCAAs) to support protein synthesis, reduce protein loss and improve nutrition — particularly in chronic liver disease, hepatic encephalopathy and convalescence.

How are Aminowise-BCAA Sachets taken?

Dissolve one sachet in 100–150 ml of water or milk, twice daily before or between meals, or as advised by your physician.

Is Aminowise-BCAA available for PCD pharma franchise?

Yes, Trumac Healthcare offers Aminowise-BCAA Sachets on monopoly-based PCD pharma franchise and for third-party manufacturing.

How should Aminowise-BCAA be stored?

Store below 30 °C in a dry place, away from direct sunlight. Keep sachets sealed until use.

Is Aminowise-BCAA WHO-GMP certified?

Yes, Aminowise-BCAA Sachets are manufactured in WHO-GMP and FSSAI compliant facilities.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.